Inventor · disambiguated record
Nathan Fitzsimmons
Also filed as: FITZSIMMONS NATHAN
2 granted patents·14 pending applications·12 citations·filing 2018–2024
58Inventor score
Top patents by PatentIndex Score
16 records- 0183US11026896B2Transdermal penetrant formulations containing cannabidiolAMPERSAND BIOPHARMACEUTICALS INC·Filed 2019·Granted Jun 8, 2021·7 cites·10 claims
- 0281US10842758B1Transdermal penetrant formulations containing cannabidiolAMPERSAND BIOPHARMACEUTICALS INC·Filed 2019·Granted Nov 24, 2020·5 cites·16 claims
- 0371US2019083527A1Method of administration and treatmentAMPERSAND BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0465US2024226000A9Transdermal penetrant formulations for administration of medicamentsDYVE BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0561US2024390265A1Formulations for transdermal administration of active agentsDYVE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0660US2024424016A1Buffering for non-alcoholic steatohepatitis and liver diseasesDYVE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0757US2023038462A1Transdermal penetrant formulations containing cannabidiolDYVE BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 0856US2021268122A1Inhibition of spontaneous metastasis via protein inhibitors of cysteine proteasesDYVE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 0955US2019134219A1Inhibition of spontaneous metastasis via protein inhibitors of cysteine proteasesAMPERSAND BIOPHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1055US2022323344A1Transdermal penetration by modulating epithelial junctionsDYVE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1154US2022305076A1Topical cyclosporine for treating psoriasis and other ailmentsDYVE BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1252US2021386906A1Methods and formulations for transdermal administration of dermal contouring agentsDYVE BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1351US2022105062A1Transdermal penetrant formulationsDYVE BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1448US2021369769A1Management of risk of cation overload and electrolyte imbalance with topically applied buffersAMPERSAND BIOPHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1547US2021338613A1Formulations and methods for transdermal administration of ketonesDYVE BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 1640US2022031738A1Iron formulations for topical administration and methods of treatment of iron deficiencyDYVE BIOSCIENCES INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nathan Fitzsimmons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →